Joji Yui Selected Research

Joji Yui Research Topics

Disease

12	Neoplasms (Cancer) 02/2015 - 01/2005
8	Breast Neoplasms (Breast Cancer) 07/2013 - 04/2009
4	Central Nervous System Diseases (CNS Diseases) 01/2016 - 10/2012
4	Neuroinflammatory Diseases 01/2016 - 03/2012
3	Pneumonia (Pneumonitis) 01/2016 - 09/2011
3	Ischemia 09/2013 - 06/2010
2	Non-alcoholic Fatty Liver Disease 01/2016 - 11/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 11/2015
2	Melanoma (Melanoma, Malignant) 02/2015 - 10/2014
2	Infarction (Infarctions) 01/2015 - 01/2011
2	Inflammation (Inflammations) 01/2014 - 03/2012
2	Human Influenza (Influenza) 05/2011 - 01/2009
1	Schizophrenia (Dementia Praecox) 01/2017
1	Pain (Aches) 01/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Fibrosis (Cirrhosis) 11/2015
1	Alzheimer Disease (Alzheimer's Disease) 08/2015
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Carcinogenesis 10/2014
1	Huntington Disease (Huntington's Disease) 04/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2012
1	Acute Lung Injury 01/2012
1	Colonic Neoplasms (Colon Cancer) 11/2010
1	Fibrosarcoma 04/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2010
1	Brain Injuries (Brain Injury) 11/2009
1	Brain Neoplasms (Brain Tumor) 04/2009

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2009
8	LigandsIBA 02/2015 - 11/2009
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2013 - 04/2009
6	Biomarkers (Surrogate Marker)IBA 11/2015 - 11/2009
4	Glutamic Acid (Glutamate)FDA Link 01/2017 - 07/2013
4	metabotropic glutamate receptor type 1IBA 01/2016 - 10/2012
2	N-methylbenzamideIBA 10/2014 - 09/2013
2	Phosphotransferases (Kinase)IBA 08/2014 - 06/2012
2	acetamideIBA 01/2014 - 03/2012
2	cobaltous chloride (cobalt(II)chloride)IBA 06/2012 - 12/2011
2	PhosgeneIBA 06/2012 - 12/2011
2	LipopolysaccharidesIBA 01/2012 - 09/2011
2	Oseltamivir (Tamiflu)FDA Link 05/2011 - 01/2009
2	Ro 64-0802IBA 05/2011 - 01/2009
2	Phosphates (Orthophosphate)IBA 05/2011 - 01/2009
2	ElacridarIBA 02/2011 - 11/2010
2	Gefitinib (Iressa)FDA Link 04/2010 - 04/2009
1	metabotropic glutamate receptor 2IBA 01/2017
1	anandamide (arachidonylethanolamide)IBA 01/2016
1	alpha-SynucleinIBA 01/2016
1	CannabinoidsIBA 01/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2015
1	EnzymesIBA 08/2015
1	Glycogen Synthase KinasesIBA 08/2015
1	Integrin alpha5beta1IBA 01/2015
1	IntegrinsIBA 01/2015
1	Oncogene Proteins (Oncogene Protein)IBA 10/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2014
1	agerafenibIBA 08/2014
1	N- methyl- N- (1- phenylethyl)- 2- propynylamineIBA 05/2014
1	Neuroprotective AgentsIBA 09/2013
1	Methionine (L-Methionine)FDA Link 11/2012
1	PK 11195 (PK11195)IBA 11/2012
1	nasIBA 11/2012
1	Choline (Choline Chloride)IBA 11/2012
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2012
1	Glycyrrhetinic Acid (Po 12)IBA 06/2012
1	Urea (Carbamide)FDA LinkGeneric 06/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2012
1	Messenger RNA (mRNA)IBA 03/2012
1	CytokinesIBA 03/2012
1	N- benzyl- N- methyl- 2- (7,8- dihydro- 7- (2- fluoroethyl)- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 01/2012
1	BenzenesulfonamidesIBA 12/2011
1	Carbonic Anhydrase IXIBA 12/2011
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 07/2011
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2011
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2011
1	Sorafenib (BAY 43-9006)FDA Link 04/2011
1	AcidsIBA 01/2011
1	AcridinesIBA 01/2011
1	AmidesIBA 01/2011
1	tariquidar (XR9576)IBA 06/2010
1	Carbon-11IBA 04/2010
1	IonsIBA 01/2010
1	CarbonIBA 01/2010
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2010
1	EsterasesIBA 01/2009
1	ThymidineIBA 01/2005

Therapy/Procedure

2	Therapeutics 01/2016 - 04/2009
1	Drug Therapy (Chemotherapy) 06/2010